Balaji Amines Limited (BALAMINES) AI Stock Analysis

• Market Cap: ₹32.39B
• Dividend Yield: 0.97%
• Average Volume (3M): 3.13K
• Price to Earnings (P/E): 29.5
• Beta (1Y): 1.22
• Revenue Growth: -10.76%
• EPS Growth: -27.70%
• Country: IN
• Employees: 1,084
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 12.20
• Shares Outstanding: 32,401,000
• 10 Day Avg. Volume: 2,179
• 30 Day Avg. Volume: 3,132
• PEG Ratio: -1.11
• Price to Book (P/B): 2.20
• Price to Sales (P/S): 2.91
• P/FCF Ratio: 46.43
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 41.45
• Revenue Forecast (FY): ₹13.64B

• Rating: 69 Neutral
• Price Target: ₹1,095.00 ▲(0.39% Upside)
• Action: Reiterated Date: 01/09/26
• Date: Action: Reiterated 01/09/26

The score is driven primarily by strong financial quality (low leverage and positive free cash flow), partially offset by mixed technicals (negative MACD and below longer-term moving averages) and a middling valuation (P/E 27.17 with a low ~0.90% dividend yield).

Positive Factors

Strong balance sheet

A low debt profile gives Balaji Amines durable financial flexibility to fund maintenance and growth capex, absorb cyclical downturns in chemical demand, and support working capital needs for exports. This reduces refinancing and solvency risk over the next several quarters.

Positive free cash flow

Consistent positive free cash flow underpins the company's ability to self-fund downstream integration, repay liabilities, and invest in productivity or specialty capacity. Reliable cash generation supports long-term operational stability and strategic reinvestment.

Diverse end markets & downstream mix

Serving multiple industrial end-markets and producing downstream derivatives reduces single-industry cyclicality and helps sustain margins. The ability to shift sales mix toward higher-value derivatives supports steadier revenue and margin resilience over time.

Negative Factors

Recent revenue and EPS decline

Contraction in revenue and sharply lower EPS indicate weakening demand or competitive pressure that can persist across quarters. Sustained top-line and earnings declines constrain reinvestment, weaken margin leverage, and challenge long-term growth targets if not reversed.

Raw-material cost sensitivity

Profitability depends on volatile feedstock prices and utilization. Inability to fully pass higher input costs to customers or maintain utilization can compress margins persistently. This structural exposure makes margins cyclical despite specialty positioning.

Product concentration in amines

A business concentrated in aliphatic amines limits diversification benefits; sector-specific demand shocks or pricing pressure in amines can disproportionately affect revenue. Long-term resilience depends on successful expansion of differentiated downstream and specialty products.

Balaji Amines Limited Business Overview & Revenue Model

Company Description

Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India. The company operates through three segments: Amines & Speciality Chemicals, Hotel, and CFL Lamps. It offers monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, dimethyl and diethyl amino ethanol; and specialty chemicals, including N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, and acetonitrile. The company also provides derivatives comprising di-methyl acetamide, di-methyl amine hydrochloride, tri-methyl amine hydrochloride, di-ethyl amine hydrochloride, tri-ethyl amine hydrochloride, di-methyl urea, and choline chloride; and pharma excipients, such as poly vinyl pyrrolidone. It serves pharmaceutical, agrochemical, paint and resin, animal feed, oil and gas, rubber cleaning chemical, dye and textile, and water treatment chemical industries. In addition, the company operates Balaji Sarovar, a hotel in Solapur, Maharashtra; and manufactures and sells CFL lamps. It also exports its products to the United States, Europe, China, Turkey, Korea, Malaysia, Kuwait, and internationally. The company was incorporated in 1988 and is based in Hyderabad, India.

How the Company Makes Money

Balaji Amines primarily makes money by manufacturing and selling chemicals (mainly aliphatic amines and their derivatives) to industrial customers. Revenue is generated through (1) sale of core amines (commodity-to-specialty intermediates) where volumes and realized prices drive topline, (2) sale of higher value-added amine derivatives and downstream/specialty products that typically carry different margin profiles than base amines, and (3) exports, where the same product portfolio is sold to international customers and revenues depend on global demand, realized export pricing, and currency movements. Its earnings are influenced by input/raw-material costs, plant utilization, and the extent of integration into downstream derivatives (which can shift the mix toward value-added products). Specific details such as customer concentration, named long-term offtake contracts, or disclosed strategic partnerships are not available in the provided prompt; null.

Balaji Amines Limited Financial Statement Overview

Summary

Overall financials are solid: a strong balance sheet with low leverage (82) and positive free cash flow with healthy cash conversion (79). Income statement performance is resilient (76), but recent revenue and net income contraction temper the score.

Income Statement

Balaji Amines has shown resilience in its income statement despite revenue fluctuations. The Gross Profit Margin and Net Profit Margin have been reasonably stable, reflecting effective cost management. However, the recent contraction in revenue and net income suggests challenges in market conditions or competition.

Balance Sheet

The balance sheet is strong, with a low Debt-to-Equity Ratio indicating conservative financial leverage. The equity ratio is robust, showcasing a solid capital structure. However, the company should watch for any increase in liabilities that could affect its financial stability.

Cash Flow

Cash flow metrics reveal effective cash management, with positive Free Cash Flow indicating the ability to sustain operations and investments. While the Operating Cash Flow to Net Income ratio is healthy, the company must focus on improving cash flow growth to support future expansions.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	13.64B	13.97B	16.08B	23.38B	23.20B	13.11B
Gross Profit	5.56B	4.88B	3.50B	8.39B	8.57B	5.39B
EBITDA	2.52B	2.65B	3.53B	6.24B	6.36B	3.79B
Net Income	1.46B	1.58B	2.05B	3.26B	3.68B	2.38B
Balance Sheet
Total Assets	23.31B	22.52B	21.46B	19.63B	18.75B	13.10B
Cash, Cash Equivalents and Short-Term Investments	1.86B	3.50B	3.31B	3.09B	515.37M	173.23M
Total Debt	314.46M	110.27M	196.97M	575.74M	1.01B	1.27B
Total Liabilities	2.75B	2.34B	2.53B	2.65B	5.60B	4.00B
Stockholders Equity	18.82B	18.45B	17.22B	15.54B	12.50B	8.94B
Cash Flow
Free Cash Flow	-1.62B	874.82M	704.14M	2.62B	842.07M	-221.07M
Operating Cash Flow	222.05M	2.73B	3.34B	3.82B	2.32B	1.10B
Investing Cash Flow	-1.15B	-1.61B	-1.64B	-1.86B	-1.47B	-615.89M
Financing Cash Flow	-169.00M	-447.73M	-749.66M	-812.33M	-565.13M	-374.51M

Balaji Amines Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1090.80
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BALAMINES, the sentiment is Negative. The current price of 1090.8 is above the 20-day moving average (MA) of 1059.72, below the 50-day MA of 1114.82, and below the 200-day MA of 1359.04, indicating a bearish trend. The MACD of -30.48 indicates Positive momentum. The RSI at 37.19 is Neutral, neither overbought nor oversold. The STOCH value of 36.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:BALAMINES.

Balaji Amines Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BALAMINES	69 Neutral	₹32.39B	29.53	―	0.97%	-10.76%	-27.70%
ANURAS	66 Neutral	₹140.70B	76.50	―	0.06%	69.32%	113.55%
ROSSARI	64 Neutral	₹23.44B	24.59	―	0.09%	15.47%	-1.72%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
ALKYLAMINE	61 Neutral	₹65.31B	48.28	―	0.62%	3.95%	8.28%
NEOGEN	61 Neutral	₹35.85B	211.46	―	0.09%	8.44%	-35.59%
FAIRCHEMOR	47 Neutral	₹6.47B	-2,425.33	―	1.07%	-22.10%	-85.56%

Balaji Amines Limited Corporate Events

Balaji Amines Opens Special Window for Transfer and Demat of Physical Shares

Balaji Amines Limited has announced that it has published newspaper advertisements in The Indian Express and Lokmat regarding a special window for the transfer and dematerialisation of physical shares. The move reflects the company’s ongoing compliance with SEBI Listing Regulations and supports the broader transition toward dematerialised holdings, potentially improving ease of share transfer and transparency for its investors.

The company has also informed that the details of this special window and related disclosures are available on its official website. By proactively communicating through multiple channels, Balaji Amines aims to ensure that shareholders holding physical share certificates are aware of the opportunity to convert to demat form, aligning with market-wide efforts to modernise and secure shareholding records.